Legislation · British Columbia · Provincial
Bill M 249 — Pharmaceutical Risk Management and Accountability Act
Clarion tracks Bill M 249 before British Columbia — its status, sponsor, plain-language summary, and every stage it moves through, each cited to the official record.
- Status
- First reading
- Sponsor
- Tara Armstrong
- Introduced
- 2026-05-28
- Session
- 2nd Session, 43rd Parliament
See what's moving in Canadian policy — get The Dispatch, our free weekly read.
What it does
AI plain-language summary of the official text.
Bill M 249, titled the Pharmaceutical Risk Management and Accountability Act, has been introduced in the British Columbia Legislative Assembly during the 2nd Session of the 43rd Parliament. The bill is currently at First Reading, meaning it has been formally introduced but has not yet been debated or advanced through the legislative process. Based on its long title, the bill appears to address risk management and accountability measures related to pharmaceuticals, though specific provisions are not yet available at this stage.
Track Bill M 249 — and everything like it
Set a topic, and Clarion grades the bills, debates, and lobbying filings it ingests to your files — with a calibrated passage forecast and an AI clerk that answers from the record and cites it.